Form 4: Surmodics CFO Timothy J. Arens Reports Stock Transactions
SEC Form 4 Filing
Chief Financial Officer of Surmodics, Timothy J. Arens, reports the exercise of stock options and subsequent disposal of shares to cover tax obligations.
Summary
- On August 16, 2024, Timothy J. Arens, the Chief Financial Officer of Surmodics Inc., exercised employee stock options to acquire 18,447 shares of common stock at a price of $33.20.
- Following the exercise of these options, Arens disposed of 16,729 shares at a price of $40.06 to satisfy tax obligations.
- After these transactions, Arens directly owns 77,359 shares of Surmodics common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects routine transactions related to executive compensation and tax obligations.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor management's alignment with shareholder interests. These filings are publicly available and closely watched by investors seeking insights into company performance and management's confidence.
Key Dates
| Date | Description |
|---|---|
| 08/16/2024 | Date of stock option exercise and share disposal. |
| 08/20/2024 | Date of signature on the Form 4 filing. |
| 11/28/2024 | Expiration date of employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.